Excess Copper Chelating Therapy for Wilson Disease Induces Anemia and Liver Dysfunction

被引：11

作者：

Harada, Masaru ^{[1
]}

Miyagawa, Koichiro ^{[1
]}

Honma, Yuichi ^{[1
]}

Hiura, Masaaki ^{[1
]}

Shibata, Michihiko ^{[1
]}

Matsuhashi, Toru ^{[1
]}

Abe, Shintaro ^{[1
]}

Harada, Riko ^{[1
]}

Tabaru, Akinari ^{[1
]}

机构：

[1] Univ Occupat & Environm Hlth, Japan Sch Med, Dept Internal Med 3, Tokyo, Japan

来源：

INTERNAL MEDICINE | 2011年 / 50卷 / 14期

关键词：

ceruloplasmin; chelating therapy; hemochromatosis; Wilson disease; ACQUIRED SIDEROBLASTIC ANEMIA; LATE ENDOSOMES; IRON; GENE; CERULOPLASMIN; ATP7B; ACERULOPLASMINEMIA; FERROPORTIN; DIAGNOSIS; HEPCIDIN;

D O I：

10.2169/internalmedicine.50.5209

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 37-year-old man was diagnosed with Wilson disease at the age of 14. His first manifestations were neurological. He was treated with trientine for more than 10 years and suffered from anemia and liver dysfunction. Wilson disease is a genetic disorder characterized by accumulation of copper in the body. Excess copper is toxic, but copper is an essential trace element. Copper-binding ceruloplasmin is important for iron metabolism. Excess copper chelating treatment-induced anemia and iron deposition in the liver was suspected. Proper monitoring of copper status is important for the management of Wilson disease.

引用

页码：1461 / 1464

页数：4

共 50 条

[11] Combination Therapy Using Chelating Agent and Zinc for Wilson's Disease
Chen, Jui-Chi
Chuang, Cheng-Hung
Wang, Jing-Doo
Wang, Chi-Wei
JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2015, 35 (06) : 697 - 708
[12] Hyaluronate/black phosphorus complexes as a copper chelating agent for Wilson disease treatment
Seong-Jong Kim
Hye Hyeon Han
Sei Kwang Hahn
Biomaterials Research, 25
[13] Combination Therapy Using Chelating Agent and Zinc for Wilson’s Disease
Jui-Chi Chen
Cheng-Hung Chuang
Jing-Doo Wang
Chi-Wei Wang
Journal of Medical and Biological Engineering, 2015, 35 : 697 - 708
[14] Is liver copper quantitation mandatory to exclude Wilson disease?
Gow, PJ
Angus, PW
Smith, AL
Wall, AJ
Smallwood, RA
Sewell, RB
GASTROENTEROLOGY, 1998, 114 (04) : A1248 - A1248
[15] Encephalopathy in Wilson Disease: Copper Toxicity or Liver Failure?
Ferenci, Peter
Litwin, Tomasz
Seniow, Joanna
Czlonkowska, Anna
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 : S88 - S95
[16] Coomb's Negative Hemolytic Anemia and Liver Disease: A Case of Wilson Disease
Barnes, Tanganyika
Kim, Katherine
Arrigo, Richard
Tumer, Gizem
Peters, Stephen
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S148 - S148
[17] LIMITATIONS AND LONG TERM OUTCOME OF TREATMENT WITH COPPER CHELATING AGENTS OR ZINC IN WILSON DISEASE
Weiss, Karl Heinz
Merle, Uta
Klemm, Daniela
Schaefer, Mark
Ferenci-Foerster, Daniela
Gotthardt, Daniel
Stremmel, Wolfgang
Ferenci, Peter
HEPATOLOGY, 2008, 48 (04) : 1168A - 1168A
[18] Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy
Jayantee Kalita
Vijay Kumar
Abhay Ranjan
Usha K. Misra
NeuroMolecular Medicine, 2015, 17 : 364 - 372
[19] Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy
Kalita, Jayantee
Kumar, Vijay
Ranjan, Abhay
Misra, Usha K.
NEUROMOLECULAR MEDICINE, 2015, 17 (04) : 364 - 372
[20] Effect of Copper Staining in Wilson Disease: A Liver Explant Study
Karadag, Nese
Tolan, Kerem
Samdanci, Emine
Selimoglu, Ayse
Akpolat, Nusret
Yilmaz, Sezai
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (05) : 542 - 546

← 1 2 3 4 5 →